{"id":"https://openalex.org/W4410803051","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.8500","title":"First-line adagrasib (ADA) with pembrolizumab (PEMBRO) in patients (pts) with advanced/metastatic KRAS G12C -mutated non-small cell lung cancer (NSCLC) from the phase 2 portion of the KRYSTAL-7 study.","display_name":"First-line adagrasib (ADA) with pembrolizumab (PEMBRO) in patients (pts) with advanced/metastatic KRAS G12C -mutated non-small cell lung cancer (NSCLC) from the phase 2 portion of the KRYSTAL-7 study.","publication_year":2025,"publication_date":"2025-05-28","ids":{"openalex":"https://openalex.org/W4410803051","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.8500"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2025.43.16_suppl.8500","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.8500","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.8500","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048675362","display_name":"Pasi Antero Janne","orcid":"https://orcid.org/0000-0002-7821-4928","observed_orcids":["https://orcid.org/0000-0002-7821-4928"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pasi A. J\u00e4nne","raw_affiliation_strings":["Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028538844","display_name":"Willemijn S.M.E. Theelen","orcid":"https://orcid.org/0000-0001-9772-0511","observed_orcids":["https://orcid.org/0000-0001-9772-0511"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Willemijn S.M.E. Theelen","raw_affiliation_strings":["The Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091509029","display_name":"Marina Chiara Garassino","orcid":"https://orcid.org/0000-0002-3821-5598","observed_orcids":["https://orcid.org/0000-0002-3821-5598"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Chiara Garassino","raw_affiliation_strings":["The University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044613951","display_name":"Alexander I. Spira","orcid":"https://orcid.org/0000-0003-1303-0447","observed_orcids":["https://orcid.org/0000-0003-1303-0447"]},"institutions":[{"id":"https://openalex.org/I4210122908","display_name":"Virginia Cancer Specialists","ror":"https://ror.org/03tbabt10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210122908"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander I. Spira","raw_affiliation_strings":["Virginia Cancer Specialists, Fairfax, VA; US Oncology Research, The Woodlands, TX; NEXT Oncology, Fairfax, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Cancer Specialists, Fairfax, VA; US Oncology Research, The Woodlands, TX; NEXT Oncology, Fairfax, VA","institution_ids":["https://openalex.org/I4210122908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088331751","display_name":"Janessa J. Laskin","orcid":"https://orcid.org/0000-0002-0161-9329","observed_orcids":["https://orcid.org/0000-0002-0161-9329"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Janessa J. Laskin","raw_affiliation_strings":["BC Cancer Vancouver Centre, Vancouver, BC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Vancouver Centre, Vancouver, BC, Canada","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003664573","display_name":"Filippo de Marinis","orcid":"https://orcid.org/0000-0002-1118-5536","observed_orcids":["https://orcid.org/0000-0002-1118-5536"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo de Marinis","raw_affiliation_strings":["Istituto Europeo di Oncologia, IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Europeo di Oncologia, IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052909691","display_name":"Firas Benyamine Badin","orcid":"https://orcid.org/0009-0001-0693-3747","observed_orcids":["https://orcid.org/0009-0001-0693-3747"]},"institutions":[{"id":"https://openalex.org/I4210093865","display_name":"Central Baptist Hospital","ror":"https://ror.org/00jc57298","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Firas Benyamine Badin","raw_affiliation_strings":["Baptist Health Medical Group, Lexington, KY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baptist Health Medical Group, Lexington, KY","institution_ids":["https://openalex.org/I4210093865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000363186","display_name":"Lisenka N Boom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119634","display_name":"Ziekenhuis Bethesda","ror":"https://ror.org/02hvsf428","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210119634"]},{"id":"https://openalex.org/I4210145795","display_name":"Ziekenhuis Amstelland","ror":"https://ror.org/05e73v668","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210145795"]},{"id":"https://openalex.org/I4210156613","display_name":"Ziekenhuis Bernhoven","ror":"https://ror.org/05b5x0e19","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210156613"]},{"id":"https://openalex.org/I4210157845","display_name":"St Clara Hospital","ror":"https://ror.org/05qfq7p37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210157845"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Lisenka Boom","raw_affiliation_strings":["Ziekenhuis St Jansdal, Harderwijk, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ziekenhuis St Jansdal, Harderwijk, Netherlands","institution_ids":["https://openalex.org/I4210119634","https://openalex.org/I4210145795","https://openalex.org/I4210156613","https://openalex.org/I4210157845"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019213894","display_name":"Carlos Aguado","orcid":"https://orcid.org/0000-0002-5624-8035","observed_orcids":["https://orcid.org/0000-0002-5624-8035"]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Aguado De La Rosa","raw_affiliation_strings":["Hospital Clinico Universitario San Carlos, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Clinico Universitario San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065723854","display_name":"Izabela Chmielewska","orcid":"https://orcid.org/0000-0002-0948-9071","observed_orcids":["https://orcid.org/0000-0002-0948-9071"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Izabela Chmielewska","raw_affiliation_strings":["Medical University of Lublin, Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Lublin, Lublin, Poland","institution_ids":["https://openalex.org/I121032520"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090324173","display_name":"Enriqueta Felip","orcid":"https://orcid.org/0000-0002-7620-0098","observed_orcids":["https://orcid.org/0000-0002-7620-0098"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Enriqueta Felip","raw_affiliation_strings":["Vall d\u2019Hebron Institute of Oncology, Vall d\u2019Hebron Barcelona Hospital Campus, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d\u2019Hebron Institute of Oncology, Vall d\u2019Hebron Barcelona Hospital Campus, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028746264","display_name":"Gyula Ostoros","orcid":"https://orcid.org/0000-0001-5339-7257","observed_orcids":["https://orcid.org/0000-0001-5339-7257"]},"institutions":[{"id":"https://openalex.org/I4210163183","display_name":"Orsz\u00e1gos Kor\u00e1nyi Tbc \u00e9s Pulmonol\u00f3giai Int\u00e9zet","ror":"https://ror.org/051mrhb02","country_code":"HU","type":"facility","lineage":["https://openalex.org/I4210163183"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Gyula Ostoros","raw_affiliation_strings":["National Kor\u00e1nyi Institute of Pulmonology, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Kor\u00e1nyi Institute of Pulmonology, Budapest, Hungary","institution_ids":["https://openalex.org/I4210163183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013375065","display_name":"Lauren Jimenez\u2010Kurlander","orcid":"https://orcid.org/0000-0002-9449-8588","observed_orcids":["https://orcid.org/0000-0002-9449-8588"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Jimenez-Kurlander","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050610940","display_name":"Cassie Michelle Lane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cassie M. Lane","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012980198","display_name":"Archie Sachdeva","orcid":"https://orcid.org/0000-0002-9373-8308","observed_orcids":["https://orcid.org/0000-0002-9373-8308"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Archie Sachdeva","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002461369","display_name":"Laura J. Eccles","orcid":"https://orcid.org/0009-0002-9543-1745","observed_orcids":["https://orcid.org/0009-0002-9543-1745"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Eccles","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016020113","display_name":"Shun Lu","orcid":"https://orcid.org/0000-0001-8833-7262","observed_orcids":["https://orcid.org/0000-0001-8833-7262","https://orcid.org/0000-0003-3887-4320","https://orcid.org/0000-0002-1833-475X"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2802608112","display_name":"Shanghai Chest Hospital","ror":"https://ror.org/03fjc3817","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802608112"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shun Lu","raw_affiliation_strings":["Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2802608112"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"16_suppl","first_page":"8500","last_page":"8500"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adagrasib","display_name":"adagrasib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/kras-g12c-mutation","display_name":"KRAS G12C mutation","score":0.921999990940094},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/pd-l1-tumor-proportion-score","display_name":"PD-L1 tumor proportion score","score":0.7749999761581421},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7039999961853027},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9390000104904175},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.9390000104904175},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.7319999933242798},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.49399998784065247},{"id":"https://openalex.org/keywords/kras-inhibitors","display_name":"KRAS inhibitors","score":0.7070000171661377},{"id":"https://openalex.org/keywords/metastatic-lung-cancer","display_name":"metastatic lung cancer","score":0.6629999876022339},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.3880000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7941542863845825},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5968568325042725},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5745726227760315},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.5495622158050537},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5124731659889221},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4992945194244385},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4639297127723694},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.40238064527511597},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3857474625110626},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.1248999834060669},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.12047144770622253},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2025.43.16_suppl.8500","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.8500","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.8500","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3136615392","https://openalex.org/W4242549773","https://openalex.org/W2056220279","https://openalex.org/W4405750198","https://openalex.org/W2007484137","https://openalex.org/W3206021689","https://openalex.org/W2081952763","https://openalex.org/W4231671096","https://openalex.org/W2072312249","https://openalex.org/W2124872203"],"abstract_inverted_index":{"8500":[0],"Background:":[1],"In":[2,294],"the":[3,50,215,322],"phase":[4,341],"2":[5],"KRYSTAL-7":[6],"study":[7],"(NCT04613596),":[8],"first-line":[9,79,302,327,347],"ADA,":[10,282],"a":[11,21,311,326,396,428],"KRAS":[12,29,68,298,328,357],"G12C":[13,30,69,299,329,358],"inhibitor,":[14],"plus":[15,85,133,304,331,349],"PEMBRO":[16,86,134,305,350,352],"demonstrated":[17,306],"clinical":[18,308],"activity":[19],"and":[20,33,46,72,110,120,148,188,265,286,291,310,361,366,436,449],"manageable":[22,312],"safety":[23,47,313],"profile":[24],"in":[25,214,227,232,252,257,263,270,334,354],"pts":[26,57,129,230,295,355],"with":[27,66,178,197,296,356],"advanced/metastatic":[28,67,297],"-mutated":[31,70,300,359],"NSCLC":[32,71,360],"PD-L1":[34,60,74,210,317,362,373,375],"\u226550%":[35],"(Garassino":[36],"et":[37],"al.":[38],"Ann":[39],"Oncol":[40],"2023).":[41],"Here":[42],"we":[43],"report":[44],"efficacy":[45,309],"data,":[48,55],"including":[49],"first":[51],"disclosure":[52],"of":[53,107,124,183,202,221,229,316,344],"survival":[54,112,118],"for":[56,281,284,288],"across":[58],"all":[59],"tumor":[61,75],"expression":[62],"levels.":[63],"Methods:":[64],"Pts":[65],"known":[73],"proportion":[76],"score":[77],"received":[78,131],"ADA":[80,132,290,303,348],"(400":[81],"mg":[82,88],"orally":[83],"BID)":[84],"(200":[87],"IV":[89],"Q3W).":[90],"The":[91,243,272,340],"primary":[92],"endpoint":[93],"was":[94,142,155,162,172,191,279],"investigator-assessed":[95],"objective":[96],"response":[97,108],"rate":[98,182,201,274],"(ORR)":[99],"per":[100,209],"RECIST":[101],"v1.1.":[102],"Secondary":[103],"endpoints":[104],"included":[105],"duration":[106],"(DOR)":[109],"progression-free":[111],"(PFS)":[113],"assessed":[114],"by":[115],"investigator,":[116],"overall":[117],"(OS),":[119],"safety.":[121],"Results:":[122],"As":[123],"August":[125],"23,":[126],"2024,":[127],"149":[128],"had":[130,150],"(median":[135],"OS":[136,190,200,412,443],"follow-up":[137,431,444],"22.8":[138],"mo):":[139],"median":[140,160,170,189],"age":[141],"67":[143],"years,":[144],"48%":[145],"were":[146,225,237,250],"female,":[147],"62%":[149],"ECOG":[151],"PS":[152],"1.":[153],"ORR":[154],"44.3%":[156],"(95%":[157,165,175,185,194,204,388,399,403,416,420],"CI":[158,166,176,186,195,205,380],"36.2\u201352.7);":[159],"DOR":[161],"26.3":[163],"mo":[164,174,193,387,398,415,433,438,446,451],"14.9\u2013not":[167],"estimable":[168],"[NE]);":[169],"PFS":[171,181,395,430],"11.0":[173],"5.8\u201314.0)":[177],"an":[179,198],"18-mo":[180,199],"37.6%":[184],"29.0\u201346.1);":[187],"18.3":[192],"14.3\u2013NE)":[196],"51.8%":[203],"43.0\u201359.8).":[206],"Efficacy":[207],"outcomes":[208],"status":[211],"are":[212],"shown":[213],"Table.":[216],"Treatment-related":[217],"adverse":[218],"events":[219],"(TRAEs)":[220],"any":[222],"grade":[223],"(G)":[224],"reported":[226,238],"94.6%":[228],"(G3/4":[231],"68.4%);":[233],"three":[234],"G5":[235],"TRAEs":[236,247,278],"(pneumonia":[239],"[n=2];":[240],"pneumonitis":[241],"[n=1]).":[242],"most":[244],"common":[245],"hepatic":[246,277],"(any":[248],"G)":[249],"increases":[251],"alanine":[253],"aminotransferase":[254,260],"(39.6%;":[255],"G3/4":[256,262,269],"11.4%),":[258],"aspartate":[259],"(35.6%;":[261],"14.1%),":[264],"alkaline":[266],"phosphatase":[267],"(19.5%;":[268],"6.7%).":[271],"discontinuation":[273],"due":[275],"to":[276,338],"2.0%":[280],"6.7%":[283],"PEMBRO,":[285],"0.7%":[287],"both":[289],"PEMBRO.":[292],"Conclusions:":[293],"NSCLC,":[301],"promising":[307],"profile,":[314],"regardless":[315],"status.":[318],"These":[319],"data":[320],"represent":[321],"largest":[323],"dataset":[324],"evaluating":[325],"inhibitor":[330,333],"PD-(L)1":[332],"this":[335],"population":[336],"presented":[337],"date.":[339],"3":[342],"portion":[343],"KRYSTAL-7,":[345],"comparing":[346],"vs":[351],"monotherapy":[353],"\u226550%,":[363],"is":[364],"ongoing":[365],"recruiting.":[367],"Clinical":[368],"trial":[369],"information:":[370],"NCT04613596":[371],".":[372],"<50%(n=95)":[374],"\u226550%(n=54)":[376],"ORR,":[377],"n":[378],"(%)95%":[379],"34":[381],"(35.8)26.2\u201346.3":[382],"32":[383],"(59.3)45.0\u201372.4":[384],"Median":[385,394,411,429,442],"DOR,":[386],"CI)":[389,404,421],"(n=34)18.2":[390],"(11.1\u2013NE)":[391],"(n=32)26.3":[392],"(26.3\u2013NE)":[393],",":[397,414],"CI)18-mo":[400,417],"rate,":[401,418],"%":[402,419],"6.9":[405],"(3.9\u201312.4)29.8":[406],"(19.8\u201340.4)":[407],"27.7":[408],"(8.1\u2013NE)50.7":[409],"(35.5\u201364.0)":[410],"b":[413,441],"15.5":[422],"(11.1\u201321.0)45.2":[423],"(34.3\u201355.6)":[424],"NE":[425],"(15.4\u2013NE)62.4":[426],"(47.5\u201374.1)":[427],"17.5":[432],"(PD-L1":[434,439,447,452],"<50%)":[435,448],"22.6":[437],"\u226550%);":[440],"21.4":[445],"24.9":[450],"\u226550%).":[453]},"counts_by_year":[{"year":2026,"cited_by_count":19},{"year":2025,"cited_by_count":6}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}